Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
TRICUSPID VALVE-IN-VALVE IN EBSTEIN’S ANOMALY: A FEASIBLE CHALLENGE
Anno:
2026
Degeneration of tricuspid bioprostheses represents a relevant clinical issue in patients with complex congenital heart disease, such as Ebstein’s anomaly, in whom redo cardiac surgery is associated with high morbidity and mortality. We report the case of a 75-year-old woman with Ebstein’s anomaly who had previously undergone double surgical…
INTEGRATED ECHOCARDIOGRAPHIC ASSESSMENT OF SEVERE TRICUSPID REGURGITATION AND OUTCOMES AFTER TRANSCATHETER THERAPY
Anno:
2026
The management of severe tricuspid regurgitation (TR) remains a major clinical challenge, particularly in elderly patients at high surgical risk. Two- and three-dimensional transthoracic (TTE) and transesophageal echocardiography (TEE) play a pivotal role in the anatomical and functional assessment of the tricuspid valve, patient selection and post-procedural follow-up. Methods….
PARAVALVULAR LEAK AND HAEMOLYTIC ANAEMIA, WHEN THE SIZE MATTERS
Anno:
2026
Background Paravalvular leak (PVL) is a complication of valve replacement with 1% to 3% of patients developing symptoms including heart failure or haemolysis. The correlation between the size of the leak and the severity of haemolysis is unclear. Small leaks can cause severe haemolysis, whereas significant leaks may cause…
UN UNUSUAL CASE OF TRICUSPID REGURGITATION
Anno:
2026
BACKGROUNG Significant tricuspid regurgitation affects 3–6% of the general population and is associated with reduced quality of life, increased hospitalizations and mortality. Echocardiography is the first-line imaging modality for assessing etiology, mechanism, and severity. CLINICAL CASE We describe a 58-year-old woman with hypertension and active smoking, without significant prior…
GLP1-RA SEMAGLUTIDE AND SLOWING PROGRESSION OF AORTIC VALVE STENOSIS IN NON DIABETIC PATIENTS
Anno:
2026
We investigated predictors of aortic stenosis (AS) progression in 20 consecutive patients (pts) every 6 months for 24 months with clinical controls, echocardiograms and biochemical variables. The changes evuated were: every 6 months clinical status and mean gradient [MG], peak velocity [PV], peak gradient [PG], or aortic valve area…